AGL 6.80 No Change ▼ 0.00 (0%)
ANL 9.38 Increased By ▲ 0.16 (1.74%)
AVN 76.80 Increased By ▲ 2.60 (3.5%)
BOP 5.43 No Change ▼ 0.00 (0%)
CNERGY 4.93 Increased By ▲ 0.04 (0.82%)
EFERT 78.15 Increased By ▲ 0.15 (0.19%)
EPCL 55.30 Increased By ▲ 0.60 (1.1%)
FCCL 15.15 Increased By ▲ 0.22 (1.47%)
FFL 6.31 Decreased By ▼ -0.03 (-0.47%)
FLYNG 7.25 Increased By ▲ 0.13 (1.83%)
GGGL 10.45 Decreased By ▼ -0.11 (-1.04%)
GGL 16.55 Increased By ▲ 0.12 (0.73%)
GTECH 8.29 Increased By ▲ 0.08 (0.97%)
HUMNL 6.37 Increased By ▲ 0.02 (0.31%)
KEL 2.97 Increased By ▲ 0.02 (0.68%)
LOTCHEM 28.51 Decreased By ▼ -0.09 (-0.31%)
MLCF 27.90 Increased By ▲ 0.10 (0.36%)
OGDC 75.40 Increased By ▲ 0.10 (0.13%)
PAEL 15.94 Increased By ▲ 0.14 (0.89%)
PIBTL 5.58 Decreased By ▼ -0.02 (-0.36%)
PRL 17.02 Decreased By ▼ -0.20 (-1.16%)
SILK 1.06 No Change ▼ 0.00 (0%)
TELE 10.55 Increased By ▲ 0.25 (2.43%)
TPL 8.06 Increased By ▲ 0.06 (0.75%)
TPLP 20.89 Increased By ▲ 0.09 (0.43%)
TREET 23.08 Increased By ▲ 0.48 (2.12%)
TRG 132.19 Increased By ▲ 3.34 (2.59%)
UNITY 22.95 Increased By ▲ 0.45 (2%)
WAVES 11.64 Decreased By ▼ -0.36 (-3%)
WTL 1.12 Decreased By ▼ -0.01 (-0.88%)
BR100 4,130 Increased By 30.8 (0.75%)
BR30 15,689 Increased By 155.9 (1%)
KSE100 41,287 Increased By 158.8 (0.39%)
KSE30 15,458 Increased By 120.7 (0.79%)
Follow us

OCCUPIED JERUSALEM: The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

The survey was carried out on healthcare workers at the largest hospital in Israel, which on December 19 launched a mass vaccination campaign regarded as the world's fastest.

Israeli studies have found the vaccine developed by US pharma giant Pfizer and its German partner BioNTech to be 95 percent effective one week after a second jab, while the Lancet report focused on more than 9,000 medical staff at Sheba hospital near Tel Aviv.

Some 7,000 of them received the first dose and the rest were not inoculated.

From the group, 170 were diagnosed with Covid-19 after tests carried out only on those showing symptoms or who had been in contact with coronavirus carriers.

Fifty-two percent of them were found to have not been vaccinated.

Comparing the two groups, the Sheba study calculated that the vaccine was 47 percent effective between one and 14 days after inoculation, rising to 85 percent after 15 to 28 days.

Comments

Comments are closed.